Blog: Opioid epidemic - The pain persists

pills drugs pharmaceuticals

A Sunday Times investigation recently revealed Britain is in danger of replicating the painkiller epidemic that has ravaged the US — particularly in the north, where the drugs are prescribed four times more than in London. Dorothy Flower, partner, and Emma Kislingbury, associate at RPC, explore how this might impact pharmaceutical companies, medical practitioners, healthcare providers, and their insurers.

‘Epidemic’, ‘crisis’, ‘timebomb’; these are, unfortunately, all too familiar terms used to describe the impact opioids - a class of drugs that include the illegal drug heroin, synthetic opioids such

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Inflation issues remain despite drop in rate

Speaking at the Insurance Post Claims Club, Allianz’s chief claims officer Graham Gibson stated that the latest inflation figures seen this week will not trickle down to insurance any time soon.

Building Back Better at Chelsea Flower Show

Flood Re’s Build Back Better scheme is being used to not only fund internal flood resilience changes but also adaptations to outside space and gardens in the quest to stop and reduce flood waters entering properties, explains Stephen Linklater, claims director of Ageas.

Insurers face margin crush unless premiums are hiked

Data analysis: A sustainable margin recovery looks increasingly challenging for insurers with premiums needing to increase in real terms to prevent any erosion after a tripling of costs to 10.9% of premiums last year from 3.5% in 2022.